Australia markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.22+0.06 (+0.14%)
At close: 04:00PM EST
42.47 +0.25 (+0.59%)
Pre-market: 05:10AM EST
Show:
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
30,328,000
-
29,324,000
24,696,000
24,354,000
Cost of revenue
8,565,000
-
9,554,000
8,163,000
7,929,000
Gross profit
21,763,000
-
19,770,000
16,533,000
16,425,000
Operating expenses
Research development
6,223,000
-
5,488,000
5,019,000
4,793,000
Selling general and administrative
9,385,000
-
8,372,000
7,070,000
7,437,000
Total operating expenses
15,018,000
-
13,041,000
11,655,000
11,847,000
Operating income or loss
6,745,000
-
6,729,000
4,878,000
4,578,000
Interest expense
792,000
-
826,000
764,000
847,000
Income before tax
6,064,000
-
5,628,000
3,599,000
5,170,000
Income tax expense
756,000
-
707,000
83,000
67,000
Income from continuing operations
5,308,000
-
4,921,000
3,516,000
5,103,000
Net income
4,928,000
-
14,956,000
4,385,000
5,749,000
Net income available to common shareholders
4,928,000
-
14,956,000
4,385,000
5,749,000
Basic EPS
3.00
2.43
7.43
2.19
2.89
Diluted EPS
2.96
2.40
7.32
2.17
2.85
Basic average shares
2,022,750
2,026,000
2,013,000
2,001,200
1,990,400
Diluted average shares
2,051,750
2,055,500
2,042,000
2,026,000
2,015,200